Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1971 4
1972 1
1973 8
1974 4
1975 5
1976 21
1977 21
1978 10
1979 6
1980 5
1981 12
1982 9
1983 9
1984 12
1985 6
1986 14
1987 9
1988 5
1989 9
1990 12
1991 11
1992 6
1993 6
1994 8
1995 6
1996 2
1997 2
1998 2
1999 6
2000 3
2001 3
2004 2
2005 1
2006 1
2008 1
2009 1
2012 3
2013 2
2014 2
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

252 results

Results by year

Filters applied: . Clear all
Page 1
Azapropazone - its place in the management of rheumatoid conditions.
Brooks PM, Buchanan WW. Brooks PM, et al. Curr Med Res Opin. 1976;4(1):94-100. doi: 10.1185/03007997609109288. Curr Med Res Opin. 1976. PMID: 770085 Review.
The authors review the trials carried out on azapropazone in rheumatoid arthritis and other rheumatoid conditions. ...Its main advantages are its low incidence of side-effects and the fact that in the majority of the trials reported azapropazone treatment was prefer …
The authors review the trials carried out on azapropazone in rheumatoid arthritis and other rheumatoid conditions. ...Its main advant …
Azapropazone (Rheumox).
[No authors listed] [No authors listed] Drug Ther Bull. 1976 Dec 17;14(26):102-3. Drug Ther Bull. 1976. PMID: 795626 Clinical Trial. No abstract available.
Azapropazone in aspirin intolerance.
Gutgesell C, Fuchs T. Gutgesell C, et al. Allergy. 1999 Aug;54(8):897-8. doi: 10.1034/j.1398-9995.1999.00268.x. Allergy. 1999. PMID: 10485401 No abstract available.
The amphiprotic character of azapropazone and its relevance to the gastric mucosa.
McCormack K, Brune K. McCormack K, et al. Arch Toxicol. 1990;64(1):1-6. doi: 10.1007/BF01973369. Arch Toxicol. 1990. PMID: 2407231 Review.
Of those NSAIDs commercially available in the United Kingdom azapropazone remains the only one for which amphiprotic behaviour has been described. Following our examination of available data for azapropazone we conclude that the use of amphiprotic compounds represen …
Of those NSAIDs commercially available in the United Kingdom azapropazone remains the only one for which amphiprotic behaviour has be …
The pharmacology and pharmacokinetics of azapropazone - a review.
Jones CJ. Jones CJ. Curr Med Res Opin. 1976;4(1):3-16. doi: 10.1185/03007997609109277. Curr Med Res Opin. 1976. PMID: 770078 Review.
The pharmacology and pharmacokinetic properties of azapropazone, a new anti-inflammatory analgesic, are reviewed. Anti-inflammatory activity was assessed by standard in vivo and in vitro methods. ...In man, the biological half life was approximately 20 hours. Azapropazo …
The pharmacology and pharmacokinetic properties of azapropazone, a new anti-inflammatory analgesic, are reviewed. Anti-inflammatory a …
Azapropazone and warfarin.
Beeley L. Beeley L. BMJ. 1991 Jun 1;302(6788):1341. doi: 10.1136/bmj.302.6788.1341-a. BMJ. 1991. PMID: 2059705 Free PMC article. No abstract available.
Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project).
Castellsague J, Riera-Guardia N, Calingaert B, Varas-Lorenzo C, Fourrier-Reglat A, Nicotra F, Sturkenboom M, Perez-Gutthann S; Safety of Non-Steroidal Anti-Inflammatory Drugs (SOS) Project. Castellsague J, et al. Drug Saf. 2012 Dec 1;35(12):1127-46. doi: 10.2165/11633470-000000000-00000. Drug Saf. 2012. PMID: 23137151 Free PMC article. Review.
Pooled RR ranged from 1.43 (95% CI 0.65, 3.15) for aceclofenac to 18.45 (95% CI 10.99, 30.97) for azapropazone. RR was less than 2 for aceclofenac, celecoxib (RR 1.45; 95% CI 1.17, 1.81) and ibuprofen (RR 1.84; 95% CI 1.54, 2.20); 2 to less than 4 for rofecoxib (RR 2.32; 9 …
Pooled RR ranged from 1.43 (95% CI 0.65, 3.15) for aceclofenac to 18.45 (95% CI 10.99, 30.97) for azapropazone. RR was less than 2 fo …
Apazone.
[No authors listed] [No authors listed] 2020 Jul 20. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2020 Jul 20. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999744 Free Books & Documents. Review.
Apazone (azapropazone) is not approved for marketing in the United States by the U.S. ...
Apazone (azapropazone) is not approved for marketing in the United States by the U.S. ...
Comparative trial of azapropazone and indomethacin plus allopurinol in acute gout and hyperuricaemia.
Fraser RC, Davis RH, Walker FS. Fraser RC, et al. J R Coll Gen Pract. 1987 Sep;37(302):409-11. J R Coll Gen Pract. 1987. PMID: 3330140 Free PMC article. Clinical Trial.
This study compared the effects of azapropazone and indomethacin plus allopurinol in the management of acute gout and hyperuricaemia. ...Fewer breakthrough attacks of gout occurred in the azapropazone group (12) than the indomethacin/allopurinol group (21).Although …
This study compared the effects of azapropazone and indomethacin plus allopurinol in the management of acute gout and hyperuricaemia. …
Effects of azapropazone on pain-related brain activity in human subjects.
Lötsch J, Mohammadian P, Hummel T, Florin S, Brune K, Geisslinger G, Kobal G. Lötsch J, et al. Br J Clin Pharmacol. 1995 Dec;40(6):545-52. doi: 10.1111/j.1365-2125.1995.tb05799.x. Br J Clin Pharmacol. 1995. PMID: 8703660 Free PMC article. Clinical Trial.
At the subjective level, analgesic effects of azapropazone were observed in the ratings of tonic pain. 4. Analgesic properties of azapropazone were demonstrated in man. The topographical pattern of the changes in the CSSERPs and the effects on EEG background activit …
At the subjective level, analgesic effects of azapropazone were observed in the ratings of tonic pain. 4. Analgesic properties of …
252 results